American Portfolios Advisors’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

American Portfolios Advisors’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-558	Closed	-$10.4K	–	3666
2022 Q1	$10.4K	Hold	558	–	–	﹤0.01%	2673
2021 Q4	$11.9K	Hold	558	–	–	﹤0.01%	2550
2021 Q3	$10.3K	Hold	558	–	–	﹤0.01%	2552
2021 Q2	$11.9K	Hold	558	–	–	﹤0.01%	2438
2021 Q1	$10.8K	Buy	+558	New	+$9.83K	﹤0.01%	2351

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

American Portfolios Advisors's OCDX Position: Q2 2022 in Review

American Portfolios Advisors sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 558 shares — an estimated $10.4K sold.

American Portfolios Advisors first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $11.9K in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

American Portfolios Advisors reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
American Portfolios Advisors sold 558 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $10.4K.
American Portfolios Advisors first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
American Portfolios Advisors's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $11.9K in Q2 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.